Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
132 participants
INTERVENTIONAL
2012-04-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02612337
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
NCT04674735
OTO-104 for the Treatment of Meniere's Disease
NCT01412177
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
NCT04815187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
V0251
V0251
single dose
Placebo
placebo
single dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
V0251
single dose
placebo
single dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 to 70 years
* Acute vertigo attack due to vestibular disorder
Exclusion Criteria
* Concomitant central neurological disorder
* Psychogenic vertigo
* Use of ototoxic drugs causing vertigo or dizziness within the last month
* Use of anti-dizziness medications from the onset of symptoms, except if the dosage had been stable for at least 3 months
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pierre Fabre Medicament
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fakultni Nemocnice Hradec Králové
Hradec Králové, , Czechia
Regional Hospital Kladno
Kladno, , Czechia
Faculty Hospital Ostrava
Ostrava, , Czechia
Faculty Hospital Královské Vinohrady
Prague, , Czechia
Faculty Hospital Motol
Prague, , Czechia
Thomayer's Teaching Hospital
Prague, , Czechia
Strepomrauska Nemocaicni a. S.
Prostějov, , Czechia
CHI Elbeuf-Louviers-Val de Reuil
Elbeuf, , France
Hôpital Nord
Marseille, , France
CHU de Rouen, Hopital Charles Nicolle
Rouen, , France
Hôpital Nord
Saint-Etienne, , France
Hopital Purpan
Toulouse, , France
Universitätsklinikum Aachen
Aachen, , Germany
HELIOS Klinikum Berlin-Buch
Berlin, , Germany
Park - Klinik Weissensee
Berlin, , Germany
Allgemeines Krankenhaus Celle
Celle, , Germany
Universitätsklinikum Essen
Essen, , Germany
Goethe-University
Frankfurt am Main, , Germany
Universitätsklinikum Schleswig-Holstein Campus Lübeck
Lübeck, , Germany
University Hospital Mannheim
Mannheim, , Germany
Universitätsklinikum München
München, , Germany
Semmelweis Egyetem Neurológiai Klinika
Budapest, , Hungary
Debreceni Egyetem Orvos- és Egészségtudományi Centrum
Debrecen, , Hungary
Petz Aladár Megyei Oktató Kórház
Győr, , Hungary
Kaposi Mór Megyei Oktató Kórhaz
Kaposvár, , Hungary
Borsod Abaúj Zemplén Megyei Kórház és Egyetemi Oktató Kórház
Miskolc, , Hungary
Kanizsai Dorottya Kórház
Nagykanizsa, , Hungary
Pécsi Tudományegyetem Általános Orvostudományi Kar
Pécs, , Hungary
Soproni Erzsébet Oktató Kórház
Sopron, , Hungary
Markusovszky County Hospital
Szombathely, , Hungary
Complejo H.Universitario de Badajoz
Badajoz, , Spain
Hospital de Poniente
El Ejido, , Spain
Hospital Universitario de Getafe
Getafe -Madrid, , Spain
Hospital Comarcal San Agustin
Linares, , Spain
Hospital Gregorio Marañón
Madrid, , Spain
Clinica Universitaria de Navarra
Pamplona, , Spain
Complejo Hospitalario de Pontevedra- Montecelo
Pontevedra, , Spain
H. Clínico de Salamanca
Salamanca, , Spain
Hospital Clinico Universitario
Santiago de Compostela, , Spain
Hospital Universitario La Fe
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-003412-23
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
V0251 IV 202 4A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.